201 related articles for article (PubMed ID: 36889548)
1. Colorectal Neoplasia 10 Years or More Following Negative Colonoscopy: Time to Extend Recommended Surveillance Intervals?
Forbes N
Gastroenterology; 2023 Aug; 165(2):512. PubMed ID: 36889548
[No Abstract] [Full Text] [Related]
2. Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program.
Wassie MM; Young GP; Winter JM; Cock C; Bampton P; Rahman M; Heddle R; Fraser R; Meng R; Symonds EL
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2389-2398.e2. PubMed ID: 36610499
[TBL] [Abstract][Full Text] [Related]
3. Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasia.
Wassie MM; Young GP; Cock C; Bampton P; Winter JM; Simpson K; Saluja H; Chuang A; Fraser RJ; Symonds EL
J Gastroenterol Hepatol; 2022 Jun; 37(6):1067-1075. PubMed ID: 35261071
[TBL] [Abstract][Full Text] [Related]
4. Risk of metachronous neoplasia on surveillance colonoscopy in young patients with colorectal neoplasia.
Kim HG; Cho YS; Cha JM; Shin JE; Kim KO; Yang HJ; Koo HS; Joo YE; Boo SJ
Gastrointest Endosc; 2018 Mar; 87(3):666-673. PubMed ID: 28619245
[TBL] [Abstract][Full Text] [Related]
5. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
Engel C; Vasen HF; Seppälä T; Aretz S; Bigirwamungu-Bargeman M; de Boer SY; Bucksch K; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Järvinen H; Kloor M; von Knebel Doeberitz M; Koornstra JJ; van Kouwen M; Langers AM; van de Meeberg PC; Morak M; Möslein G; Nagengast FM; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Sanduleanu S; Schackert HK; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vecht J; Verhulst ML; de Vos Tot Nederveen Cappel W; Zachariae S; Mecklin JP; Loeffler M;
Gastroenterology; 2018 Nov; 155(5):1400-1409.e2. PubMed ID: 30063918
[TBL] [Abstract][Full Text] [Related]
6. Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study.
van Heijningen EM; Lansdorp-Vogelaar I; Steyerberg EW; Goede SL; Dekker E; Lesterhuis W; ter Borg F; Vecht J; Spoelstra P; Engels L; Bolwerk CJ; Timmer R; Kleibeuker JH; Koornstra JJ; de Koning HJ; Kuipers EJ; van Ballegooijen M
Gut; 2015 Oct; 64(10):1584-92. PubMed ID: 25586057
[TBL] [Abstract][Full Text] [Related]
7. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification of advanced colorectal neoplasia after baseline colonoscopy: Cohort study of 17 Japanese community practices.
Shono T; Oyama S; Oda Y; Yokomine K; Murakami Y; Miyamoto H; Tanaka M; Naoe H; Sasaki Y;
Dig Endosc; 2020 Jan; 32(1):106-113. PubMed ID: 31429986
[TBL] [Abstract][Full Text] [Related]
9. The influence of the surveillance time interval on the risk of advanced neoplasia after non-advanced adenoma removal.
Hamarneh Z; Cock C; Young GP; Bampton PA; Fraser R; Ang FL; Kholmurodova F; Symonds EL
Med J Aust; 2021 Nov; 215(10):465-470. PubMed ID: 34386988
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up.
Carballal S; Sánchez A; Moreira L; Cuellar-Monterrubio JE; Bernuy J; Daca M; Ortiz O; Ocaña T; Rivero-Sánchez L; Jung G; Serradesanferm A; Pozo A; Grau J; Torá I; Zaffalon D; Castells A; Pellisé M; Balaguer F;
Endoscopy; 2022 Jul; 54(7):688-697. PubMed ID: 34607378
[TBL] [Abstract][Full Text] [Related]
11. Long-term cumulative incidence of metachronous advanced colorectal neoplasia after colonoscopy and a novel risk factor: a cohort study.
Omata F; Deshpande GA; Suzuki H; Hayashi K; Ishii N; Matoba K; Ohmuro A; Rai F; Takashima M; Fukuda K; Masuda K; Kumakura Y
Eur J Gastroenterol Hepatol; 2021 Nov; 33(11):1341-1347. PubMed ID: 34402471
[TBL] [Abstract][Full Text] [Related]
12. Metachronous Advanced Neoplasia on Surveillance Colonoscopy in Patients With Young- vs Older-onset of Colorectal Cancer.
Tjaden J; Muller C; Wideroff G; Ma K; Satiya J; Sussman D; Yen E; Kupfer SS; Melson J
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1967-1969. PubMed ID: 31351134
[TBL] [Abstract][Full Text] [Related]
13. Risk of metachronous neoplastic lesions during post-polypectomy surveillance in individuals with advanced colorectal neoplasia at initial screening colonoscopy.
Sekiguchi M; Kakugawa Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Matsuda T
J Gastroenterol Hepatol; 2021 Aug; 36(8):2230-2238. PubMed ID: 33626598
[TBL] [Abstract][Full Text] [Related]
14. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.
Collins MG; Teo E; Cole SR; Chan CY; McDonald SP; Russ GR; Young GP; Bampton PA; Coates PT
BMJ; 2012 Jul; 345():e4657. PubMed ID: 22833618
[TBL] [Abstract][Full Text] [Related]
15. A Review of the Management of Sporadic Colorectal Adenomas in Young People: Is Surveillance Wasted on the Young?
Bushyhead D; Lin OST; Kozarek RA
Dig Dis Sci; 2019 Aug; 64(8):2107-2112. PubMed ID: 30788685
[TBL] [Abstract][Full Text] [Related]
16. Five-year colon surveillance after screening colonoscopy.
Lieberman DA; Weiss DG; Harford WV; Ahnen DJ; Provenzale D; Sontag SJ; Schnell TG; Chejfec G; Campbell DR; Kidao J; Bond JH; Nelson DB; Triadafilopoulos G; Ramirez FC; Collins JF; Johnston TK; McQuaid KR; Garewal H; Sampliner RE; Esquivel R; Robertson D
Gastroenterology; 2007 Oct; 133(4):1077-85. PubMed ID: 17698067
[TBL] [Abstract][Full Text] [Related]
17. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
[TBL] [Abstract][Full Text] [Related]
18. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies.
Singh H; Turner D; Xue L; Targownik LE; Bernstein CN
JAMA; 2006 May; 295(20):2366-73. PubMed ID: 16720822
[TBL] [Abstract][Full Text] [Related]
19. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
[TBL] [Abstract][Full Text] [Related]
20. Impact of physician compliance with colonoscopy surveillance guidelines on interval colorectal cancer.
Nayor J; Saltzman JR; Campbell EJ; Perencevich ML; Jajoo K; Richter JM
Gastrointest Endosc; 2017 Jun; 85(6):1263-1270. PubMed ID: 27889548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
